mibefradil has been researched along with Melanoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bahí, N; Cantí, C; Das, A; Herreros, J; Martí, RM; Matias-Guiu, X; Pamplona, R; Pushparaj, C; Sorolla, A; Vilella, R | 1 |
| Hata, R; Kato, Y; Kubota, E; Miyazaki, K; Ozawa, S; St-Pierre, Y; Tsukuda, M | 1 |
2 other study(ies) available for mibefradil and Melanoma
| Article | Year |
|---|---|
Functional expression of voltage-gated calcium channels in human melanoma.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Calcium; Calcium Channel Blockers; Calcium Channels; Cell Cycle; Cell Hypoxia; Cell Line, Tumor; Cell Lineage; Cell Proliferation; Cell Survival; Flow Cytometry; Fura-2; Gene Expression Regulation, Neoplastic; Humans; Manganese; Melanocytes; Melanoma; Mibefradil; Molecular Imaging; Protein Isoforms; Reverse Transcriptase Polymerase Chain Reaction; Skin Neoplasms; Up-Regulation | 2012 |
Acidic extracellular pH increases calcium influx-triggered phospholipase D activity along with acidic sphingomyelinase activation to induce matrix metalloproteinase-9 expression in mouse metastatic melanoma.
Topics: Animals; Calcium; Calcium Channel Blockers; Calcium Channels; Cell Line, Tumor; Chelating Agents; Desipramine; Egtazic Acid; Enzyme Activation; Extracellular Fluid; Hydrogen-Ion Concentration; Indolizines; MAP Kinase Signaling System; Matrix Metalloproteinase 9; Melanoma; Mibefradil; Mice; NF-kappa B; Nimodipine; Perhexiline; Phenethylamines; Phospholipase D; Phosphorylation; Promoter Regions, Genetic; Sphingomyelin Phosphodiesterase | 2007 |